Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.
about
Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.Electroporation and transcutaneous sampling (ETS) of acyclovir.Skin and skin structure infections: treatment with newer generation fluoroquinolones.Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate.Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureusAntagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infectionEfficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureusEfficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses.
P2860
Q33982620-04BD461F-27F7-4CBF-9EA9-D979E09183DFQ36498743-781DCFE7-B39D-45AE-BFBA-1B6CC96F53DCQ37116838-777746F2-589F-4AD4-A15E-F2CF4DB9F6EEQ39657998-E7D3389D-4399-42CE-AA7E-9FDEA70614B6Q40903164-7257E8DA-4A4D-402F-9E9A-0938FCAA2603Q41913615-957F47F9-8A78-4C62-9B9D-9A51A834F692Q42008069-95EF3197-B6AF-4325-8CBF-807AC3C89C42Q42036509-2BE25CC9-30F4-4619-92C3-E30D04E74EAAQ42529961-A72DBA0E-E81F-4845-BE48-A52B3AB9E34DQ42586714-B6E0E93A-B4F0-4DD4-9A5B-6576BD7C1DD8Q43970889-2F0EE8CF-A6AC-482A-80BC-290ACADD2D27
P2860
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@ast
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@en
type
label
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@ast
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@en
prefLabel
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@ast
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@en
P2093
P2860
P1476
Pharmacokinetics and pharmacod ...... s in human skin blister fluid.
@en
P2093
P2860
P304
P356
10.1128/AAC.44.5.1352-1355.2000
P407
P577
2000-05-01T00:00:00Z